Emerging Therapeutic Targets: Rheumatoid Arthritis

  • College of Pharmacy, University of Sargodha, Sargodha, Pakistan
  • College of Pharmacy, University of Sargodha, Sargodha, Pakistan
  • District Head Quarter (DHQ) Teaching Hospital Sargodha, Sargodha, Pakistan
  • Sargodha Medical College, Sargodha, Pakistan
Keywords: rheumatoid arthritis, therapeutics, innovative targets

Abstract

Rheumatoid arthritis involves a range of various intricate pathophysiologic facets that contribute to synovitis, synovial hyperplasia, autoantibodies generation as well as cartilage and bone damage leading to functional impairment. Although current therapeutic modalities including NSAIDs, corticosteroids, DMARDs and biologic response modifiers target various contributory factors but still not effectual in the apt management of rheumatoid arthritis, thus pointing towards the investigation of new prospects to not only manage but cure this perplexing disorder. Hence, Tumor necrosis factor-α converting enzyme (TACE/ADAM17), Toll like receptor 5 (TLR5), Citrullinated immunoglobulin binding protein (citBiP), anti-BRAF autoantibodies, Perforin and membrane attack complex (MAC), Migration inhibitory factor of macrophages (MIF), Mucin (MUCs), IL-1β, NLRP3 inflammasome signaling, NETosis, Hepatocyte growth factor (HGF), progranulin, PTPN22, iRHOM2, immune mediated immunolytic pathways, tenascin-C and various chemokines are intriguing areas, which in future might be more beneficial in the treatment and management of arthritis in majority of populace with minimum risks.

 

Author Biographies

, College of Pharmacy, University of Sargodha, Sargodha, Pakistan

Department of Pharmacology,

, College of Pharmacy, University of Sargodha, Sargodha, Pakistan

Department of Pharmacology, 

, Sargodha Medical College, Sargodha, Pakistan

Department of Community Medicine, 

Published
2018-11-23
Section
Review Article